The Human Microbiome: from Sequencing to Therapeutics
Originally Aired: June 15, 2018
The human microbiome is emerging as a critical modulator of multiple aspects of host physiology and health. Changes in microbiome composition and behavior have now been associated with pathophysiological disorders in multiple organ systems. Importantly, a number of studies are beginning to reveal the potential of the microbiome and microbially synthesized—as well as derived—products in their ability to treat infection, inflammatory and autoimmune disease, and cancer, among other illnesses.
In this Cell Press webinar, Rob Knight (University of California, San Diego), Michael Fischbach (University of California, San Francisco), and Elaine Hsiao (University of California, Los Angeles) will explore how this field is forging ahead by integrating sequencing approaches with physiology and small-molecule therapeutics.
Professor, Department of Pediatrics; Professor, Department of Computer Science
University of California, San Diego
Associate Professor, Department of Bioengineering
University of California, San Francisco
Assistant Professor, Department of Integrative Biology and Physiology
University of California, Los Angeles